Both in Pharmaceuticals
Corvus Pharmaceuticals vs Jade Biosciences
Over the past year CRVS returned +36.0% and JBIO returned +64.1%; their daily moves had a correlation of 0.29.
CRVS +36.0% JBIO +64.1%Growth of $1, one year, split-adjusted
| Metric | CRVS | JBIO |
|---|---|---|
| Price | $10.39 | $14.77 |
| Market cap | $874.0M | $939.3M |
| Today | +5.70% | +1.37% |
| 1 month | −1.6% | +10.1% |
| 6 months | −32.8% | −41.2% |
| Year to date | +34.9% | −4.3% |
| 1 year | +35.3% | +56.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $215.2M | $461.2M |
| Dividend yield | — | — |
| Volatility (60d) | 51.3% | 52.2% |
| Short % of float | 25.5% | 20.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).